78 followers
tunlametinib of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant mel https://t.co/lZiVsdjZPh https://t.co/7I5bXPqK3c
tunlametinib of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant mel https://t.co/lZiVsdjZPh https://t.co/7I5bXPqK3c
New Research: Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma https://t.co/RuqcSmt1Fs #pharmacology